Skip to main content
. 2023 Sep 12;19(3):298–306. doi: 10.13004/kjnt.2023.19.e42

TABLE 2. Studies on resumption timing for anticoagulation or antiplatelet therapy.

Study population Suggested resumption timing Authors Year
Parenteral anticoagulants (heparin or enoxaparin) Traumatic intracerebral hemorrhage Within 7 days of injury Chipman et al.5) 2020
Traumatic intracerebral hemorrhage 13 days after the injury. Byrnes et al.4) 2012
Oral anticoagulants (warfarin, rivaroxaban, apixaban, edoxaban, dabigatran) Spontaneous intracranial hemorrhage 10–30 weeks after hemorrhage Majeed et al.20) 2010
Spontaneous intracranial hemorrhage 6–8 weeks after hemorrhage Moon et al.23) 2022
Anticoagulant or antiplatelet Spontaneous intracerebral hemorrhage 7–8 weeks after hemorrhage Pennlert et al.30) 2017
Traumatic brain injury 7–9.5 days after injury Puckett et al.32) 2018
Traumatic subdural hemorrhage Anticoagulant: 30 days after injury Naylor et al.25) 2021
Antiplatelet: 16 days after injury.